[Infliximab as treatment for a severe outbreak of ulcerative colitis] (Q80815582)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

[Infliximab as treatment for a severe outbreak of ulcerative colitis] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

P Ruiz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

P San Salvador

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

J Ortiz de Zárate

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

P Cabezudo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

L Marcé

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

F Polo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

S Blanco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

V Orive

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

publication date

1 August 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

Gastroenterología y Hepatología

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

430-431

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.

3 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970494-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Infliximab for treatment of steroid-refractory ulcerative colitis

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970494-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial.

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0210-5705%2803%2970494-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0210-5705(03)70494-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15461945%20AND%20SRC:MED&resulttype=core&format=json